This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tianyin Pharmaceutical Co Inc (TPI)

AMEX: Health Care

Company Income Statement
Jun 2014 Jun 2013 Jun 2012 Jun 2011
Sales 46.56M 67.50M 69.61M 95.20M
Cost of Sales 28.09M 39.06M 44.06M 51.51M
Gross Operating Profit 18.47M 28.44M 25.55M 43.69M
Selling, General, and Administrative Expenses 12.25M 15.79M 14.93M 23.36M
Research & Development 946.30K 895.00K 860.08K 1.07M
Operating Income before D & A (EBITDA) 5.27M 11.75M 9.76M 19.26M
Depreciation & Amortization 2.59M 2.44M 1.22M 1.19M
Interest Income 165.53K 162.56K 209.04K 132.77K
Other Income - Net -3.07M 0.00 189.27K 1.63M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -220.73K 9.48M 8.94M 19.83M
Interest Expense 392.01K 437.90K 331.33K 119.51K
Pre-Tax Income -612.74K 9.04M 8.61M 19.71M
Income Taxes 195.32K 2.42M 2.37M 4.09M
Minority Interest -163.12K -56.98K -116.77K -40.24K
Net Income From Continuing Operations -808.07K 6.62M 6.24M 15.62M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -808.07K 6.62M 6.24M 15.62M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -644.95K 6.67M 6.36M 15.66M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-808.07K 6.62M 6.24M 15.62M
Preferred Dividends
Net Income Available To Common -808.07K 6.62M 6.24M 15.62M
Basic EPS from Continuing Ops. -0.02 0.23 0.22 0.55
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.02 0.23 0.22 0.55
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) -0.01 0.00 0.00 0.00
Basic EPS, Total -0.03 0.23 0.22 0.55
Basic Normalized Net Income/Share -0.02 0.23 0.22 0.55
EPS fr Continuing Ops. -0.02 0.23 0.22 0.53
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.02 0.23 0.22 0.53
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) -0.01 0.00 0.00 0.00
EPS, Total -0.03 0.23 0.22 0.53
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.02 0.23 0.22 0.53
Dividends Paid per Share 0.00 0.00 0.00 0.00
TPI News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

TPI Tianyin Pharmaceutical Co Inc

Chart of TPI

Analysts Ratings for TPI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell
GET TPI ANALYST REPORT

TPI Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs